Last updated: 2026-10-13 21:55:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Amneal Pharmaceuticals, Inc. (AMRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $19.59, with a market capitalization of $6.93B and a P/E ratio of 44.33. Over the past 52 weeks, its price has ranged from $9.56 to $21.18. This page covers its latest market performance, valuation, price trends and company information.
$6.93B | |
$20.05 | |
$24.48 | |
$1.24 | |
$20.03 | |
1.32M | |
2.33M | |
44.33 | |
$21.18 | |
$9.56 | |
-- | |
-- |
Amneal Pharmaceuticals, Inc. (AMRX) is trading at $19.80 in after-hours trading as of 2026-10-13 21:29:00, down 1.15% ($0.23) from the regular-session close of $20.03.
After-hours trading shows how investors are pricing AMRX after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Amneal Pharmaceuticals, Inc. (AMRX) moved from $20.30 to $19.59, representing a decline of 3.52% ($0.71).
The stock traded between $18.97 and $20.60 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 3.56 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 86.3%
AMRX is currently trading at $19.59, placing it 86.3% of the way from its 52-week low of $9.56 to its 52-week high of $21.18. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 8500 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Amneal Pharmaceuticals, Inc. (AMRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.